Page last updated: 2024-09-03

iguratimod and Leukemia

iguratimod has been researched along with Leukemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aikawa, Y; Asaoka, K; Inaba, T; Kawasaki, H; Tanaka, K; Yoshida, C	1

Other Studies

1 other study(ies) available for iguratimod and Leukemia

Article	Year
Pharmacological studies on 3-formylamino-7-methylsulfonylamino-6-phenoxy-4H-1-benzopyran-4-one (T-614), a novel antiinflammatory agent. 4th communication: inhibitory effect on the production of interleukin-1 and interleukin-6. Journal of pharmacobio-dynamics, 1992, Volume: 15, Issue:11 Topics: Anti-Inflammatory Agents, Non-Steroidal; Benzopyrans; Cell Line; Drug Interactions; Humans; Indomethacin; Interleukin-1; Interleukin-6; Leukemia; Lipopolysaccharides; Monocytes; Sulfonamides	1992

Article

Year

Pharmacological studies on 3-formylamino-7-methylsulfonylamino-6-phenoxy-4H-1-benzopyran-4-one (T-614), a novel antiinflammatory agent. 4th communication: inhibitory effect on the production of interleukin-1 and interleukin-6.

Journal of pharmacobio-dynamics, 1992, Volume: 15, Issue:11

Topics: Anti-Inflammatory Agents, Non-Steroidal; Benzopyrans; Cell Line; Drug Interactions; Humans; Indomethacin; Interleukin-1; Interleukin-6; Leukemia; Lipopolysaccharides; Monocytes; Sulfonamides

1992